Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 420


Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis.

Corona G, Minhas S, Giwercman A, Bettocchi C, Dinkelman-Smit M, Dohle G, Fusco F, Kadioglou A, Kliesch S, Kopa Z, Krausz C, Pelliccione F, Pizzocaro A, Rassweiler J, Verze P, Vignozzi L, Weidner W, Maggi M, Sofikitis N.

Hum Reprod Update. 2019 Oct 30. pii: dmz028. doi: 10.1093/humupd/dmz028. [Epub ahead of print]


Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study.

Al-Jebari Y, Elenkov A, Wirestrand E, Schütz I, Giwercman A, Lundberg Giwercman Y.

BMJ. 2019 Sep 25;366:l5214. doi: 10.1136/bmj.l5214.


Risk of Congenital Malformations in Children Born Before Paternal Cancer.

Al-Jebari Y, Rylander L, Ståhl O, Giwercman A.

JNCI Cancer Spectr. 2018 Jun 26;2(2):pky027. doi: 10.1093/jncics/pky027. eCollection 2018 Apr.


Symptoms of sexual dysfunction among men from infertile couples: prevalence and association with testosterone deficiency.

Kruljac M, Finnbogadóttir H, Bobjer J, Giraldi A, Fugl-Meyer K, Giwercman A.

Andrology. 2019 Jul 19. doi: 10.1111/andr.12678. [Epub ahead of print]


Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study.

Al-Jebari Y, Glimelius I, Berglund Nord C, Cohn-Cedermark G, Ståhl O, Tandstad T, Jensen A, Sagstuen Haugnes H, Daugaard G, Rylander L, Giwercman A.

PLoS Med. 2019 Jun 4;16(6):e1002816. doi: 10.1371/journal.pmed.1002816. eCollection 2019 Jun.


Identification of circulating small non-coding RNAs in relation to male subfertility and reproductive hormones.

Kumar K, Trzybulska D, Tsatsanis C, Giwercman A, Almstrup K.

Mol Cell Endocrinol. 2019 Jul 15;492:110443. doi: 10.1016/j.mce.2019.05.002. Epub 2019 May 8.


Copy number of the X-linked genes TLR7 and CD40L influences innate and adaptive immune responses.

Sarmiento L, Svensson J, Barchetta I, Giwercman A, Cilio CM.

Scand J Immunol. 2019 Aug;90(2):e12776. doi: 10.1111/sji.12776. Epub 2019 Jun 18.


Sperm chromatin structure assay high DNA stainability sperm as a marker of early miscarriage after intracytoplasmic sperm injection.

Jerre E, Bungum M, Evenson D, Giwercman A.

Fertil Steril. 2019 Jul;112(1):46-53.e2. doi: 10.1016/j.fertnstert.2019.03.013. Epub 2019 Apr 28.


Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment.

Weibring K, Nord C, Ståhl O, Eberhard J, Sandberg K, Johansson H, Arver S, Giwercman A, Cohn-Cedermark G.

Ann Oncol. 2019 Apr 1;30(4):604-611. doi: 10.1093/annonc/mdz017.


National guidelines and multilingual age-adapted patient brochures and videos as decision aids for fertility preservation (FP) of children and teenagers with cancer-A multidisciplinary effort to improve children's information and access to FP in Sweden.

Rodriguez-Wallberg KA, Borgström B, Petersen C, Thurin-Kjellberg A, Mörse H, Giwercman A, Jarfelt M; Work Group UNGA (YOUNG) for the Swedish Association of Local Authorities and Regions, SALAR (Sveriges Kommuner och Landsting, SKL).

Acta Obstet Gynecol Scand. 2019 May;98(5):679-680. doi: 10.1111/aogs.13588. Epub 2019 Mar 13. No abstract available.


Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.

Nyström A, Mörse H, Nordlöf H, Wiebe K, Artman M, Øra I, Giwercman A, Henic E, Elfving M.

Acta Oncol. 2019 Feb;58(2):218-224. doi: 10.1080/0284186X.2018.1529423. Epub 2018 Dec 18.


Association between semen parameters and chance of fatherhood - a long-term follow-up study.

Malm G, Rylander L, Giwercman A, Haugen TB.

Andrology. 2019 Jan;7(1):76-81. doi: 10.1111/andr.12558. Epub 2018 Dec 7.


Association between paternal smoking at the time of pregnancy and the semen quality in sons.

Axelsson J, Sabra S, Rylander L, Rignell-Hydbom A, Lindh CH, Giwercman A.

PLoS One. 2018 Nov 21;13(11):e0207221. doi: 10.1371/journal.pone.0207221. eCollection 2018.


The Impact of the Biological Variability or Assay Performance on AMH Measurements: A Prospective Cohort Study With AMH Tested on Three Analytical Assay-Platforms.

Bungum L, Tagevi J, Jokubkiene L, Bungum M, Giwercman A, Macklon N, Andersen CY, Klausen TW, Tørring N, Kumar A, Skouby SO.

Front Endocrinol (Lausanne). 2018 Oct 16;9:603. doi: 10.3389/fendo.2018.00603. eCollection 2018.


Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, Sweden.

Levine H, Mohri H, Ekbom A, Ramos L, Parker G, Roldan E, Jovine L, Koelle S, Lindstrand A, Immler S, Mortimer S, Mortimer D, van der Horst G, Ishijima S, Aneck-Hahn N, Baldi E, Menkveld R, Rothmann SA, Giwercman A, Giwercman Y, Holmberg M, Kvist U, Björndahl L, Holmberg R, Arver S, Flanagan J, Drevet JR.

Basic Clin Androl. 2018 Oct 29;28:13. doi: 10.1186/s12610-018-0077-z. eCollection 2018.


Serum chemerin levels are negatively associated with male fertility and reproductive hormones.

Bobjer J, Katrinaki M, Dermitzaki E, Margioris AN, Giwercman A, Tsatsanis C.

Hum Reprod. 2018 Dec 1;33(12):2168-2174. doi: 10.1093/humrep/dey310.


Racial and Sociodemographic Differences of Semen Parameters Among US Men Undergoing a Semen Analysis.

Glazer CH, Li S, Zhang CA, Giwercman A, Bonde JP, Eisenberg ML.

Urology. 2019 Jan;123:126-132. doi: 10.1016/j.urology.2018.09.029. Epub 2018 Oct 6.


Impact of antioxidant treatment on DNA fragmentation index: a double-blind placebo-controlled randomized trial.

Stenqvist A, Oleszczuk K, Leijonhufvud I, Giwercman A.

Andrology. 2018 Nov;6(6):811-816. doi: 10.1111/andr.12547. Epub 2018 Oct 8.


European Academy of Andrology guideline Management of oligo-astheno-teratozoospermia.

Colpi GM, Francavilla S, Haidl G, Link K, Behre HM, Goulis DG, Krausz C, Giwercman A.

Andrology. 2018 Jul;6(4):513-524. doi: 10.1111/andr.12502. Review.


Risk of metabolic disorders in childless men: a population-based cohort study.

Bungum AB, Glazer CH, Bonde JP, Nilsson PM, Giwercman A, Søgaard Tøttenborg S.

BMJ Open. 2018 Aug 17;8(8):e020293. doi: 10.1136/bmjopen-2017-020293.


Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS.

Rastrelli G, O'Neill TW, Ahern T, Bártfai G, Casanueva FF, Forti G, Keevil B, Giwercman A, Han TS, Slowikowska-Hilczer J, Lean MEJ, Pendleton N, Punab M, Antonio L, Tournoy J, Vanderschueren D, Maggi M, Huhtaniemi IT, Wu FCW; EMAS study group.

Clin Endocrinol (Oxf). 2018 Oct;89(4):459-469. doi: 10.1111/cen.13756. Epub 2018 Jul 23.


Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest.

Alson SSE, Bungum LJ, Giwercman A, Henic E.

Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:199-204. doi: 10.1016/j.ejogrb.2018.04.039. Epub 2018 May 2.


Alterations in Serum MicroRNA Profile During Hemodialysis - Potential Biological Implications.

Trzybulska D, Eckersten D, Giwercman A, Christensson A, Tsatsanis C.

Cell Physiol Biochem. 2018;46(2):793-801. doi: 10.1159/000488737. Epub 2018 Mar 29.


Endocrine disruptors and testicular function.

Lymperi S, Giwercman A.

Metabolism. 2018 Sep;86:79-90. doi: 10.1016/j.metabol.2018.03.022. Epub 2018 Mar 29. Review.


Impact of diet and bariatric surgery on anti-Müllerian hormone levels.

Nilsson-Condori E, Hedenbro JL, Thurin-Kjellberg A, Giwercman A, Friberg B.

Hum Reprod. 2018 Apr 1;33(4):690-693. doi: 10.1093/humrep/dey032.


Impact of Di-2-Ethylhexyl Phthalate Metabolites on Male Reproductive Function: a Systematic Review of Human Evidence.

Høyer BB, Lenters V, Giwercman A, Jönsson BAG, Toft G, Hougaard KS, Bonde JPE, Specht IO.

Curr Environ Health Rep. 2018 Mar;5(1):20-33. doi: 10.1007/s40572-018-0174-3.


Impact of Kidney Transplantation on Reproductive Hormone Levels in Males: A Longitudinal Study.

Eckersten D, Giwercman A, Pihlsgård M, Bruun L, Christensson A.

Nephron. 2018;138(3):192-201. doi: 10.1159/000484992. Epub 2017 Dec 14.


High risk of hypogonadism in young male cancer survivors.

Isaksson S, Bogefors K, Ståhl O, Eberhard J, Giwercman YL, Leijonhufvud I, Link K, Øra I, Romerius P, Bobjer J, Giwercman A.

Clin Endocrinol (Oxf). 2018 Mar;88(3):432-441. doi: 10.1111/cen.13534. Epub 2018 Jan 10.


Reproductive Hormone Levels Predict Changes in Frailty Status in Community-Dwelling Older Men: European Male Ageing Study Prospective Data.

Swiecicka A, Eendebak RJAH, Lunt M, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Slowikowska-Hilczer J, Lean MEJ, Pendleton N, Punab M, Vanderschueren D, Huhtaniemi IT, Wu FCW, Rutter MK; European Male Ageing Study Group.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):701-709. doi: 10.1210/jc.2017-01172.


Elevated luteinizing hormone despite normal testosterone levels in older men-natural history, risk factors and clinical features.

Eendebak RJAH, Ahern T, Swiecicka A, Pye SR, O'Neill TW, Bartfai G, Casanueva FF, Maggi M, Forti G, Giwercman A, Han TS, Słowikowska-Hilczer J, Lean MEJ, Punab M, Pendleton N, Keevil BG, Vanderschueren D, Rutter MK, Tampubolon G, Goodacre R, Huhtaniemi IT, Wu FCW; EMAS Group.

Clin Endocrinol (Oxf). 2018 Mar;88(3):479-490. doi: 10.1111/cen.13524. Epub 2017 Dec 25.


Male factor infertility and risk of multiple sclerosis: A register-based cohort study.

Glazer CH, Tøttenborg SS, Giwercman A, Bräuner EV, Eisenberg ML, Vassard D, Magyari M, Pinborg A, Schmidt L, Bonde JP.

Mult Scler. 2017 Oct 1:1352458517734069. doi: 10.1177/1352458517734069. [Epub ahead of print]


Serum microRNAs in male subfertility-biomarkers and a potential pathogenetic link to metabolic syndrome.

Trzybulska D, Bobjer J, Giwercman A, Tsatsanis C.

J Assist Reprod Genet. 2017 Oct;34(10):1277-1282. doi: 10.1007/s10815-017-0989-0. Epub 2017 Jun 29.


Male Infertility and Risk of Nonmalignant Chronic Diseases: A Systematic Review of the Epidemiological Evidence.

Glazer CH, Bonde JP, Eisenberg ML, Giwercman A, Hærvig KK, Rimborg S, Vassard D, Pinborg A, Schmidt L, Bräuner EV.

Semin Reprod Med. 2017 May;35(3):282-290. doi: 10.1055/s-0037-1603568. Epub 2017 Jun 28. Review. No abstract available.


In memoriam: Professor Marcello Spanó (1954-2017)

Bonde JP, Giwercman A.

Rocz Panstw Zakl Hig. 2017;68(2):207-208. No abstract available.


Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data.

Swiecicka A, Lunt M, Ahern T, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Lean MEJ, Pendleton N, Punab M, Slowikowska-Hilczer J, Vanderschueren D, Huhtaniemi IT, Wu FCW, Rutter MK; EMAS Study Group.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2798-2806. doi: 10.1210/jc.2017-00090.


Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.

Isaksson S, Bogefors K, Åkesson K, Egund L, Bobjer J, Leijonhufvud I, Giwercman A.

Andrology. 2017 Sep;5(5):898-904. doi: 10.1111/andr.12383. Epub 2017 Jun 7.


MicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease.

Eckersten D, Tsatsanis C, Giwercman A, Bruun L, Pihlsgård M, Christensson A.

Nephron Extra. 2017 Apr 7;7(1):33-41. doi: 10.1159/000458711. eCollection 2017 Jan-Apr.


Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.

Bogefors C, Isaksson S, Bobjer J, Kitlinski M, Leijonhufvud I, Link K, Giwercman A.

Andrology. 2017 Jul;5(4):711-717. doi: 10.1111/andr.12354. Epub 2017 May 23.


Risk of diabetes according to male factor infertility: a register-based cohort study.

Glazer CH, Bonde JP, Giwercman A, Vassard D, Pinborg A, Schmidt L, Vaclavik Bräuner E.

Hum Reprod. 2017 Jul 1;32(7):1474-1481. doi: 10.1093/humrep/dex097.


Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study.

Overman MJ, Pendleton N, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Rastrelli G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean MEJ, Punab M, Lee DM, Correa ES, Ahern T, Laurent MR, Verschueren SMP, Antonio L, Gielen E, Rutter MK, Vanderschueren D, Wu FCW, Tournoy J; EMAS study group.

Am J Geriatr Psychiatry. 2017 Jun;25(6):662-671. doi: 10.1016/j.jagp.2017.02.004. Epub 2017 Feb 7.


Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, Boekhout A, Borgmann-Staudt A, Brown MC, Cohn R, Dirksen U, Giwercman A, Ishiguro H, Jahnukainen K, Kenney LB, Loonen JJ, Meacham L, Neggers S, Nussey S, Petersen C, Shnorhavorian M, van den Heuvel-Eibrink MM, van Santen HM, Wallace WH, Green DM.

Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8. Review. Erratum in: Lancet Oncol. 2017 Apr;18(4):e196.


Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.

Bentmar Holgersson M, Ruhayel Y, Karlsson M, Giwercman A, Bjartell A, Ohlsson C, Mellström D, Ljunggren Ö, Haghsheno MA, Damber JE, Lundberg Giwercman Y.

Cancer Causes Control. 2017 Mar;28(3):227-233. doi: 10.1007/s10552-017-0859-1. Epub 2017 Feb 7.


Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.

Bogefors K, Giwercman YL, Eberhard J, Stahl O, Cavallin-Stahl E, Cohn-Cedermark G, Arver S, Giwercman A.

Asian J Androl. 2017 Sep-Oct;19(5):538-542. doi: 10.4103/1008-682X.191126.


Frailty and bone health in European men.

Cook MJ, Oldroyd A, Pye SR, Ward KA, Gielen E, Ravindrarajah R, Adams JE, Lee DM, Bartfai G, Boonen S, Casanueva F, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Vanderschueren D, Wu FC, O'Neill TW; EMAS Study Group.

Age Ageing. 2017 Jul 1;46(4):635-641. doi: 10.1093/ageing/afw205.


Seasonal fluctuation in the secretion of the antioxidant melatonin is not associated with alterations in sperm DNA damage.

Malm G, Haugen TB, Rylander L, Giwercman A.

Asian J Androl. 2017 Jan-Feb;19(1):52-56. doi: 10.4103/1008-682X.186870.


Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS).

Han TS, Correa E, Lean ME, Lee DM, O'Neill TW, Bartfai G, Forti G, Giwercman A, Kula K, Pendleton N, Punab M, Rutter MK, Vanderschueren D, Huhtaniemi IT, Wu FC, Casanueva FF; and the EMAS Study Group.

Endocrine. 2017 Feb;55(2):456-469. doi: 10.1007/s12020-016-1135-y. Epub 2016 Oct 13.


The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.

Bonde JP, Flachs EM, Rimborg S, Glazer CH, Giwercman A, Ramlau-Hansen CH, Hougaard KS, Høyer BB, Hærvig KK, Petersen SB, Rylander L, Specht IO, Toft G, Bräuner EV.

Hum Reprod Update. 2016 Dec;23(1):104-125. Epub 2016 Sep 21. Review.


The androgen receptor gene CAG repeat 
in relation to 4-year changes in 
androgen-sensitive endpoints in 
community-dwelling older European men.

Eendebak RJ, Huhtaniemi IT, Pye SR, Ahern T, O'Neill TW, Bartfai G, Casanueva FF, Maggi M, Forti G, Alston RD, Giwercman A, Han TS, Kula K, Lean ME, Punab M, Pendleton N, Keevil BG, Vanderschueren D, Rutter MK, Tampubolon G, Goodacre R, Wu FC; EMAS Group.

Eur J Endocrinol. 2016 Dec;175(6):583-593. Epub 2016 Sep 15.


Supplemental Content

Loading ...
Support Center